Compounds > 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Head and Neck Neoplasms

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodey, GP; Dimery, IW; Goepfert, H; Legha, SS; Moran, ME; Murphy, WK; Stewart, DJ1

Other Studies

1 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Head and Neck Neoplasms

ArticleYear
Phase II study of PCNU in the treatment of head and neck carcinoma.
    Cancer treatment reports, 1984, Volume: 68, Issue:2

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Middle Aged; Neutropenia; Nitrosourea Compounds; Prognosis

1984